Clinical Trial Update: NeuraGen 3D Pilot Study [NA]

View source ↗

Summary

An early-stage clinical trial evaluating NeuraGen 3D for digital nerve injury has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digital Nerve Injury

Drugs mentioned

• NeuraGen 3D

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Digital Nerve Injury | NA | Status: TERMINATED